Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression ; volume:8 ; number:1 ; day:22 ; month:11 ; year:2018 ; pages:1-14 ; date:12.2018
Scientific reports ; 8, Heft 1 (22.11.2018), 1-14, 12.2018
- Urheber
-
Linder, Anna
Hagberg Thulin, Malin
Damber, Jan-Erik
Welén, Karin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-35332-4
- URN
-
urn:nbn:de:101:1-2019010101252809384326
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Linder, Anna
- Hagberg Thulin, Malin
- Damber, Jan-Erik
- Welén, Karin
- SpringerLink (Online service)
Ähnliche Objekte (12)
The PP2A regulator IER5L supports prostate cancer progression
G-protein regulator LGN inhibits the activity of soluble guanylyl cyclase
MTA2/NuRD as a regulator of NF-kB signalling in lung cancer progression
Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers
The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer
SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway
Duplicated RGS (Regulator of G-protein signaling) proteins exhibit conserved biochemical but differential transcriptional regulation of heterotrimeric G-protein signaling in Brassica species
G-protein Gα13 functions as a cytoskeletal and mitochondrial regulator to restrain osteoclast function
![The G-protein Gα11 [Galpha 11] is essential for hypertrophic signalling in diabetes mellitus](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
The G-protein Gα11 [Galpha 11] is essential for hypertrophic signalling in diabetes mellitus
The G-protein G-alpha-11 is essential for hypertrophic signalling in diabetes mellitus
Iroquois homeobox 4 (IRX4) derived micropeptide promotes prostate cancer progression and chemoresistance through Wnt signalling dysregulation
An RNAi screen of Rho signalling networks identifies RhoH as a regulator of Rac1 in prostate cancer cell migration
The PP2A regulator IER5L supports prostate cancer progression
G-protein regulator LGN inhibits the activity of soluble guanylyl cyclase
MTA2/NuRD as a regulator of NF-kB signalling in lung cancer progression
Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers
The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer
SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway
Duplicated RGS (Regulator of G-protein signaling) proteins exhibit conserved biochemical but differential transcriptional regulation of heterotrimeric G-protein signaling in Brassica species
G-protein Gα13 functions as a cytoskeletal and mitochondrial regulator to restrain osteoclast function
The G-protein Gα11 [Galpha 11] is essential for hypertrophic signalling in diabetes mellitus
The G-protein G-alpha-11 is essential for hypertrophic signalling in diabetes mellitus
Iroquois homeobox 4 (IRX4) derived micropeptide promotes prostate cancer progression and chemoresistance through Wnt signalling dysregulation
An RNAi screen of Rho signalling networks identifies RhoH as a regulator of Rac1 in prostate cancer cell migration
The PP2A regulator IER5L supports prostate cancer progression
G-protein regulator LGN inhibits the activity of soluble guanylyl cyclase
MTA2/NuRD as a regulator of NF-kB signalling in lung cancer progression
Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers
The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer
SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway
Duplicated RGS (Regulator of G-protein signaling) proteins exhibit conserved biochemical but differential transcriptional regulation of heterotrimeric G-protein signaling in Brassica species
G-protein Gα13 functions as a cytoskeletal and mitochondrial regulator to restrain osteoclast function
The G-protein Gα11 [Galpha 11] is essential for hypertrophic signalling in diabetes mellitus
The G-protein G-alpha-11 is essential for hypertrophic signalling in diabetes mellitus
Iroquois homeobox 4 (IRX4) derived micropeptide promotes prostate cancer progression and chemoresistance through Wnt signalling dysregulation